Attovia Therapeutics, Inc. (ATTO) vs Mesa Laboratories, Inc. (MLAB)
A side-by-side comparison of Attovia Therapeutics, Inc. and Mesa Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATTO
Attovia Therapeutics, Inc.
$18.00HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
MLAB
Mesa Laboratories, Inc.
$137.59HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — ATTO vs MLAB
growth of $100 · dividends reinvested · last 1yATTO -17.8% (-17.8%/yr)MLAB +45.7% (+45.7%/yr)MLAB compounded faster over this window
ATTO MLAB
ATTO vs MLAB: by the numbers
- •ATTO is the larger company ($775M vs $770M market cap).
- •MLAB is profitable (1.92% net margin) while ATTO runs a net loss (-4490.89%).
- •MLAB pays a dividend (0.45% yield), while ATTO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ATTO | MLAB |
|---|---|---|
| P/E ratio | N/A | 163.80 |
| PEG ratio | N/A | 12.05 |
| P/S ratio | N/A | 3.08 |
| P/B ratio | N/A | 4.08 |
| EV / EBITDA | N/A | 18.50 |
| FCF yield | N/A | 6.87% |
Profitability
| Metric | ATTO | MLAB |
|---|---|---|
| Gross margin | 40.44% | 65.99% |
| Operating margin | -4974.74% | 9.00% |
| Net margin | -4490.89% | 1.92% |
| ROE | -40.21% | 2.54% |
| ROIC | -42.83% | 3.29% |
Dividends
| Metric | ATTO | MLAB |
|---|---|---|
| Dividend yield | N/A | 0.45% |
| Payout ratio | N/A | 76.19% |
Growth (annualized)
| Metric | ATTO | MLAB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.45% |
| EPS CAGR (5Y) | N/A | 13.08% |
| FCF CAGR (5Y) | N/A | 4.63% |
| Total return CAGR (5Y) | N/A | -13.52% |
Frequently asked
- Does ATTO or MLAB pay a bigger dividend?
- MLAB pays a dividend (0.45% yield), while ATTO has no payments in the available dividend history.
- Is ATTO or MLAB more profitable?
- MLAB runs the higher net margin — ATTO at -4490.89% versus MLAB at 1.92%.
Go deeper
Dig into the metrics
Mesa Laboratories P/E ratioMesa Laboratories dividend yieldAttovia Therapeutics ROEMesa Laboratories ROEAttovia Therapeutics operating marginMesa Laboratories operating marginAttovia Therapeutics revenue growthMesa Laboratories revenue growthAttovia Therapeutics free cash flowMesa Laboratories free cash flow
Attovia Therapeutics & Mesa Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.